알레르기 염증반응에서 Siglecs의 기능
Functions of Siglecs in Allergic Inflammation
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Siglecs are sialic acid binding Ig-like lectins, subset of the immunoglobulin superfamily. They are characterized by a homologous N-terminal V-set Ig-like domain and C2 set Ig- like domains. N-terminal domains have sialic acid binding activity. In humans, 11 Siglecs have been described sialoadhesin(Siglec-1), CD22(Siglec-2), CD33(Siglec-3), MAG(Siglec-4), more recently described CD33-related Siglecs(Siglec 5-11). Siglecs express most signal via immunoreceptor tyrosine-based inhibition motif(ITIM) cytoplasmic domains. The cytoplasmic tails of all Siglecs except sialoadhesin have one or more tyrosine residues within potential signaling motifs. Inhibitory function of other Siglecs such as Siglec-7 or Siglec-9 was shown in RBL-2H3 cells. Co-crosslinking of Siglec-7 or Siglec-9 and FcεR1 substantially reduced the serotonin release of RBL-7 and RBL-9 cells. Siglec-8 is expressed on human eosinophils, mast cells and basophils. Siglec-8 has two tyrosine motifs, a proximal motif and a distal motif. They have some inhibitory functions in immune system. We have observed that Siglec-8 is able to inhibit the IgE receptor-mediated β-hexosaminidase release of RBL-2H3 cells following co-crosslinking. Co-crosslinking of Siglec-8 and FcεR1 reduced the hexosaminidase release of RBL-2H3 cells. These results show that Siglec-8 is as potent as Siglec-7 and Siglec-9 in delivering inhibitory signals to RBL-2H3 cells. Siglec-8 should be a new member of the inhibitory receptor superfamily and the membrane-proximal ITIM is essential for the inhibitory function of Siglec-8 molecules. Although these molecules present specific marker for the allergic cell types, more work is needed to understand the signaling mechanism and the role in various disease processes.
참고문헌 (32)
- "Sialoadhesin,a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains", 13, pp.4490~503 (1994)
- "Siglecs:a family of sialic acid binding lectins" (1998)
- "The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion", 345, pp.74~7 (1990)
- "I-type lectins", 270, pp.14243~14246 (1995)
- "Siglecs,sialic acids and innate immunity", 22, pp.337~342 (2001)
- "Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling", 12, pp.609~615 (2002)
- "Molecular cloning and primary structure of myelin- associated glycoprotein", 84, pp.600~4 (1987)
- "Cloning and characterization of a novel mouse Siglec, mSiglec-F : differential evolution of the mouse and human (CD33) Siglec- 3-related gene clusters", 276, pp.45128~45136 (2001)
- "A novel eosinophil specific member of the immunoglobulin superfamily", 275, pp.861~868 (2000)
- "Identification of SAF-2,a novel Siglec expressed on eosinophils,mast cells and basophils", 105, pp.1093~1100 (2000)
- "a novel sialic-acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes", 275, pp.22121~22126 (2000)
- "Characterization of Siglec-5,a novel glycoprotein expressed on myeloid cells related to CD33", 92, pp.2123~2132 (1998)
- "Identification and characterization of a novel Siglec,Siglec-7,expressed by human natural killer cells and monocytes", 274, pp.34089~34095 (1999)
- "Identification,characterization and leukocyte expression of Siglec-10,a novel human sialic acid binding receptor", 355, pp.489~497 (2001)
- "Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs. Evidence for co-evolution with sialic acid synthesis pathways", 275, pp.22127~22135 (2000)
- "Engagement of p75", AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells, 1999, pp.96, 15091~15096
- "Molecular cloning of MIS,a myeloid inhibitory Siglec that binds tyrosine phosphatases SHP-1 and SHP-2", 276, pp.14451~14458 (2001)
- "Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP- 1 and SHP-2", 96, pp.483~490 (2000)
- "The sialoadhesin CD33 is a myeloid-specific inhibitory receptor", 29, pp.3440~3449 (1999)
- "Identification and molecular cloning of p75", AIRM1,a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells, 1999, pp.190, 793~802
- "Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34＋ myeloid precursors", 30, pp.827~833 (2000)
- "The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglec-7 and -9,CD33-related Siglecs expressed on human monocytes and NK cells", 173, pp.6841~6849 (2004)
- "Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs", 272, pp.898~899 (1997)
- "Molecular characterization of a Siglec-8 variant containing cytoplasmic tyrosine-based motifs and mapping of the Siglec-8 gene", 278, pp.775~781 (2000)
- "Immunological aspects of allergic asthma", 12, pp.295~335 (1994)
- "Asthma", 344, pp.350~362 (2001)
- "Eosinophil trafficking to sites of allergic inflammation", 179, pp.163~172 (2001)
- "Ligation of Siglec-8:a selective mechanism for induction of human eosinophil apoptosis", 101, pp.5014~5020 (2003)
- "Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via Siglec-7-dependent and -independent mechanisms", 33, pp.1642~1648 (2003)
- "Immunoreceptor tyrosine-based inhibition motifs", 18, pp.286~291 (1997)
- "NK cell receptors", 16, pp.359~393 (1998)
- "Regulation of immune responses through inhibitory receptors", 17, pp.875~904 (1999)